Cameron Smith is a partner in our Melbourne biotechnology team.
Cameron has extensive experience in managing international patent portfolios in the biotechnology space. Regular counsel is provided to clients in relation to strategic planning, due diligence and patentability advice with clients ranging from publicly listed biotechnology companies to smaller startup companies and university commercialisation teams. Counsel is primarily sought after in relation to biological therapeutics such as CAR-T, antibodies and stem cells as well as diagnostics and mRNA therapeutics. Cameron was recognised as an MIP Rising Star in 2018 and 2019 and as a Notable Practitioner in 2023